Cardiovascular implications of the factor V Leide... [Am Heart J. 2000] - PubMed

loading

Review Factor V Leiden as a common genetic risk factor for venous thromboembolism. [J Nurs Scholarsh. 2006]
Review Factor V Leiden as a common genetic risk factor for venous thromboembolism.
Horne MK 3rd, McCloskey DJ. J Nurs Scholarsh. 2006; 38(1):19-25.
Review Obstetric implications of activated protein C resistance and factor V Leiden mutation. [Obstet Gynecol Surv. 2000]
Review Obstetric implications of activated protein C resistance and factor V Leiden mutation.
Gherman RB, Goodwin TM. Obstet Gynecol Surv. 2000 Feb; 55(2):117-22.
Review Activated protein C resistance and factor V Leiden: a review. [Arch Pathol Lab Med. 2007]
Review Activated protein C resistance and factor V Leiden: a review.
Rosendorff A, Dorfman DM. Arch Pathol Lab Med. 2007 Jun; 131(6):866-71.
Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism. [Am J Med. 2001]
Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.
Haim N, Lanir N, Hoffman R, Haim A, Tsalik M, Brenner B. Am J Med. 2001 Feb 1; 110(2):91-6.
Review Venous thromboembolism: implications for gene-based diagnosis and technology development. [Expert Rev Mol Diagn. 2002]
Review Venous thromboembolism: implications for gene-based diagnosis and technology development.
Hooper WC, De Staercke C. Expert Rev Mol Diagn. 2002 Nov; 2(6):576-86.

Cardiovascular implications of the factor V Leiden mutation.
Cardiovascular implications of the factor V Leiden mutation.
Am Heart J. 2000 Aug ;140(2):189-95.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed